Related Experiment Videos

Association between routine blood count-derived inflammatory markers and left ventricular hypertrophy in diabetic

Rui Wu1, Gaiqi Yao2

  • 1Department of General Practice, Peking University Third Hospital, Beijing, China.

Insights

In diabetic kidney disease (DKD) patients, elevated neutrophil counts and the systemic immune-inflammation index (SII) are linked to left ventricular hypertrophy (LVH). These inflammatory markers, along with uric acid and urea, predict LVH risk in DKD.

Area of Science:

  • Cardiovascular complications in nephrology
  • Diabetic kidney disease (DKD) research
  • Biomarker discovery in cardiovascular disease

Background:

  • Adverse cardiovascular events are a major complication in DKD.
  • Left ventricular hypertrophy (LVH) is a significant predictor of cardiovascular events in DKD.
  • Low-grade inflammation in DKD exacerbates kidney and cardiovascular damage.

Purpose of the Study:

  • To investigate the association between routine blood count-derived inflammatory markers and LVH in DKD patients.
  • To identify predictive markers for LVH in the peripheral blood of individuals with DKD.

Main Methods:

  • Cross-sectional study involving 419 DKD patients (G2-G4).
  • Patients categorized into LVH and non-LVH groups based on echocardiography.
  • Logistic regression analysis used to identify factors associated with LVH; ROC curves generated for neutrophil and SII.

Main Results:

  • Neutrophil count, Systemic Immune-Inflammation Index (SII), uric acid, and urea were positively correlated with LVH.
  • Male gender and calcium levels were negatively correlated with LVH.
  • Combined neutrophil and SII with basic variables improved LVH prediction (AUC=0.816) compared to basic variables alone (AUC=0.782).

Conclusions:

  • Neutrophil count, SII, uric acid, and urea are independent positive predictors of LVH in DKD patients (G2-G4).
  • Male gender and calcium levels are negative predictors of LVH in this population.
  • Neutrophil and SII show potential as accessible biomarkers for LVH risk stratification in DKD.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...